CAS #: 901758-09-6
Tesamorelin is a synthetic analog of GHRH, designed to modulate somatotroph axis signaling. In preclinical and experimental research, it has been studied for its ability to influence endocrine pathway activity, regulate downstream cascades, and support investigations into systemic signaling dynamics.
Tesamorelin was developed through research into GHRH peptides, building on discoveries that synthetic analogs could prolong the half-life and activity of native GHRH fragments. It was synthesized in the late 1990s and early 2000s as a stabilized peptide with improved pharmacokinetic properties, allowing for sustained endocrine pathway activation in experimental models. Research expanded into its effects on downstream signaling and systemic function, where it has remained an important tool in laboratory and preclinical studies.

CAS #: 901758-09-6
Molecular Formula: C₂₂₁H₃₆₆N₇₂O₆₇S
Molecular Weight: ~5135.9 g/mol
PubChem ID: 16132314
Tesamorelin has been studied in endocrine, signaling, and molecular models, with research highlighting its activity in somatotroph axis modulation, downstream cascades, pathway dynamics, and protein synthesis pathways. Studies also report effects on lipid pathway signaling, endocrine markers, and molecular proliferation in preclinical systems.
Key Areas of Research:
Endocrine: Somatotroph axis, signaling, cascades
Signaling: Lipid pathways, dynamics, markers
Molecular: Proliferation, remodeling, protein synthesis
Together, these findings suggest broad experimental potential for Tesamorelin across endocrine, signaling, and molecular pathways. By modulating somatotroph axis activity and influencing downstream cascades and protein synthesis processes, Tesamorelin provides a versatile research platform for exploring molecular remodeling, pathway characterization, and endocrine biology in laboratory settings.
STEP 1
Precision Lyophilization
STEP 2
Verified Purity
STEP 3
Same-Day Fulfillment
STEP 1
Precision Lyophilization
STEP 2
Verified Purity
STEP 3
Same-Day Fulfillment
Orders dispatched same-day from our U.S. facility.
Each vial contains exactly what’s shown on the label. For example, a 10mg vial has exactly 10mg of lyophilized peptide. Researchers can divide it into smaller portions—like four 2.5mg measurements—but the total amount remains 10mg.
Products from Raw Peptides do not include usage instructions, as they are strictly for in vitro research and prohibited by law for human or animal use. Misuse or unlawful application will result in permanent denial of service.